Cancer risk from low-level ionizing radiation: The role of age at exposure

Occupational Medicine - State of the Art Reviews

Volumn 16, Issue 2, 2001, Pages 191-218

  Richardson, David B ^a,c   Wing, Steve ^a   Hoffmann, Wolfgang ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF BREMEN   (Germany)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANKYLOSING SPONDYLITIS; DNA DAMAGE; DNA REPAIR; EPIDEMIOLOGY; FEMALE; FETUS; FLUOROSCOPY; GENETICS; GYNECOLOGIC DISEASE; HEAD AND NECK TUMOR; HUMAN; JAPAN; LEUKEMIA; LIFE EXPECTANCY; OCCUPATIONAL EXPOSURE; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIOACTIVE WASTE; REVIEW; RISK ASSESSMENT; SURVIVOR; TINEA CAPITIS; TUBERCULOSIS;

AGE FACTORS; BIAS (EPIDEMIOLOGY); DNA DAMAGE; DNA REPAIR; FEMALE; FETUS; FLUOROSCOPY; GENITAL DISEASES, FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; JAPAN; LEUKEMIA, RADIATION-INDUCED; LIFE EXPECTANCY; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; RADIOACTIVE FALLOUT; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; SPONDYLITIS, ANKYLOSING; SURVIVORS; TINEA CAPITIS; TUBERCULOSIS;

EID: 33748955527     PISSN: 0885114X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (130)

1. Albright JW, Albright JF: Ageing alters the competence of the immune system to control parasitic infection. Immunol Lett 40(3):279-85, 1994.
2. Astori M, Finke D, Karapetian O, Acha-Orbea H: Development of T-B cell collaboration in neonatal mice. Int Immunol 11(3):445-51, 1999.
3. Bithell JF: Statistical issues in assessing the evidence associating obstetric irradiation and childhood malignancy. In Lengfelder E, Wendhausen H (eds): Neue Bewertung des Strahlenriskos: Niedrigdosis-Strahlung und Gesundheit. Munich, MMV Medizin Verlag, 1993, pp 53-60.
4. Blocher D, Nusse M, Bryant PE: Kinetics of double strand break repair in the DNA of X-irradiated synchronized mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med 43(5):579-84, 1983.
5. Boetticher H: Abschätzung der Knochenmarksdosis bei weit zurückliegenden Röntgenuntersuchungen. In Strahlenschutz Gf, ed. Neue Bewertung des Strahlenrisikos. München, MMV Medizin Verlag GmbH, 1993, pp 61-67.
6. Boice JD, Jr., Preston D, Davis FG, Monson RR: Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125(2):214-22, 1991.
7. Bonassi S, Abbondandolo A, Camurri L, et al.: Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79(2):133-5, 1995.
8. Breslow NE, Day NE: Statistical Methods in Cancer Research: The Design and Analysis of Cohort Studies, Vol. II. Lyon: International Agency for Research on Cancer, 1987.
9. Brewen J: Cell-cycle and radiosensitivity of the chromosomes of human leukocytes. Int J Radiat Biol 9:391-397, 1965.
10. Brinkley D, Haybittle JL: The late effects of artificial menopause by X-radiation. Br J Radiol 42(499):519-21, 1969.
11. Bruckner JV: Differences in sensitivity of children and adults to chemical toxicity: the NAS panel report. Regul Toxicol Pharmacol 31(3):280-5, 2000.
12. Cardis E, Gilbert E, Carpenter L, et al.: Combined Analyses of Cancer Mortality Among Nuclear Industry Workers in Canada, the United Kingdom and the United States of America. . Lyon, France: World Health Organization, International Agency for Research on Cancer, 1995.
13. Cardis E, Gilbert ES, Carpenter L, et al.: Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 142(2):117-32, 1995.
14. Chakraborty R, Yasuda N, Denniston C, Sankaranarayanan K: Ionizing radiation and genetic risks. VII. The concept of mutation component and its use in risk estimation for Mendelian diseases. Mutat Res 400(1-2):541-52, 1998.
15. Checkoway H, Pearce NE, Crawford-Brown DJ: Research Methods in Occupational Epidemiology. New York: Oxford University Press, 1989.
16. Checkoway H, Rice CH: Time-weighted averages, peaks, and other indices of exposure in occupational epidemiology. Am J Ind Med 21(1):25-33, 1992.
17. Cohen HJ: Biology of aging as related to cancer. Cancer 74(7 Suppl):2092-2100, 1994.
18. Darby SC, Doll R, Gill SK, Smith PG: Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 55(2):179-90, 1987.
19. Darby SC, Nakashima E, Kato H: A parallel analysis of cancer mortality among atomic bomb survivors and patients with ankylosing spondylitis given X-ray therapy. J Nat Cancer Inst 75(1):1-21, 1985.
20. Darby SC, Reeves G, Key T, Doll R, Stovall M: Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer 56(6):793-801, 1994.
21. Davis FG, Boice JD, Jr., Hrubec Z, Monson RR: Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Research 49(21):6130-6, 1989.
22. Davis FG, Boice JD, Jr., Kelsey JL, Monson RR: Cancer mortality after multiple fluoroscopic examinations of the chest. J Nat Cancer Inst 78(4):645-52, 1987.
23. Delongchamp RR, Mabuchi K, Yoshimoto Y, Preston DL: Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992. Radiat Res 147(3):385-95, 1997.
24. Doll R, Smith PG: The long-term effects of x irradiation in patients treated for metropathia haemorrhagica. Br J Radiol 41(485):362-8, 1968.
25. Doll R, Wakeford R: Risk of childhood cancer from fetal irradiation. Br J Radiol 70:130-9, 1997.
26. Dupree EA, Watkins JP, Ingle JN, et al: Uranium dust exposure and lung cancer risk in four uranium processing operations. Epidemiology 6(4):370-375, 1995.
27. Frome EL, Cragle DL, Watkins JP, et al.: A mortality study of employees of the nuclear industry in Oak Ridge, Tennessee. Radiat Res 148:64-80, 1997.
28. Gilbert ES, Cragle DL, Wiggs LD: Updated analyses of combined mortality data for workers at the Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Weapons Plant. Radiat Res 136(3):408-21, 1993.
29. Gilbert ES, Omohundro E, Buchanan JA, Holter NA: Mortality of workers at the Hanford site: 1945-1986. Health Physics 64(6):577-90, 1993.
30. Goukassian D, Gad F, Yaar M, et al: Mechanisms and implications of the age-associated decrease in DNA repair capacity. J Faseb 14(10):1325-34, 2000.
31. Gundy S, Bender MA: Increased yields of exchanges but not of deletions in X-irradiated human peripheral lymphocytes following phytohemagglutinin stimulation. Radiat Res 97(3):519-25, 1984.
32. Hagmar L, Bonassi S, Stromberg U, et al.: Cancer predictive value of cytogenetic markers used in occupational health surveillance programs. Recent Results Cancer Res 154:177-84, 1998.
33. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100(1):57-70, 2000.
34. Hoelzer D: Acute lymphoblastic leukemia in adults. In Degos L, Linch D, Löwenberg B, (ed): Textbook of Malignant Hematology. London, Martin Dunitz, 1999, pp 539-62.
35. Hoffmann W, Schmitz-Feuerhake I: How radiation-specific is the dicentric assay? J Expo Anal Environ Epidemiol 9(2): 113-33, 1999.
36. Howe GR: Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the Atomic Bomb survivors study. Radiat Res 142(3):295-304, 1995.
37. Howe GR, McLaughlin J: Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res 145(6):694-707, 1996.
38. Inskip PD, Kleinerman RA, Stovall M, et al.: Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiat Res 135(1):108-124, 1993.
39. Inskip PD, Monson RR, Wagoner JK, et al.: Cancer mortality following radium treatment for uterine bleeding [published erratum appears in Radiat Res 1991 Dec;128(3):326]. Radiat Res 123(3):331-44, 1990.
40. Inskip PD, Monson RR, Wagoner JK, et al.: Leukemia following radiotherapy for uterine bleeding. Radiat Res 122(2):107-19, 1990.
41. International Agency for Research on Cancer: Ionizing Radiation, Part 1: X- and Gamma-Radiation, and Neutrons, Vol. 75. Lyon, France: IARC Press, 2000. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans)
42. International Commission on Radiological Protection: 1990 Recommendations of the International Commission on Radiological Protection, First ed, Vol. 21. Oxford: Pergamon Press, 1991.
43. Jablon S, Kato H: Childhood cancer in relation to prenatal exposure to atomic-bomb radiation. Lancet 2(7681):1000-3, 1970.
44. Kai M, Luebeck EG, Moolgavkar SH: Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Radiat Res 148(4):348-58, 1997.
45. Kato H, Yoshimoto Y, Schull WJ: Risk of cancer among children exposed to atomic bomb radiation in utero: a review. IARC Scientific Publications (96):365-74, 1989.
46. King CM, Gillespie ES, McKenna PG, Barnett YA: An investigation of mutation as a function of age in humans. Mutat Res 316(2):79-90, 1994.
47. Kirsch I: Molecular genetics of lymphogenesis: an overview. In Magrath J, ed. Blood: Principles and Practice of Hematology. London, New York, Oxford University Press, 1997, pp 253-76.
48. Kneale GW, Mancuso TF, Stewart AM: Hanford radiation study III: a cohort study of the cancer risks from radiation to workers at Hanford (1944-77 deaths) by the method of regression models in life-tables. Br J Ind Med 38(2):156-66, 1981.
49. Kneale GW, Stewart AM: Reanalysis of Hanford data: 1944-1986 deaths. Am J Ind Med 23(3):371-89, 1993.
50. Kneale GW, Stewart AM: Factors affecting recognition of cancer risks of nuclear workers. Occup Environ Med 52(8):515-23, 1995.
51. Langholz B, Thomas D, Xiang A, Stram D: Latency analysis in epidemiologic studies of occupational exposures: application to the Colorado Plateau uranium miners cohort. Am J Ind Med 35(3):246-56, 1999.
52. Leggett RW, Crawford-Brown DJ: The role of age in human susceptibility to radiation. Science Progress 68(270):227-58, 1983.
53. Lehtonen L, Eskola J, Vainio O, Lehtonen A: Changes in lymphocyte subsets and immune competence in very advanced age. J Gerontol 45(3): M108-12, 1990.
54. Little JB: Radiation carcinogenesis. Carcinogenesis 21(3):397-404, 2000.
55. Little MP, Boice JD, Jr.: Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 151(2):218-24, 1999.
56. Little MP, Charles MW: Bomb survivor selection and consequences for estimates of population cancer risks. Health Physics 59(6):765-75, 1990.
57. Little MP, De Vathaire F, Charles MW, et al: Variations with time and age in the risks of solid cancer incidence after radiation exposure in childhood. Stat Med 17(12):1341-55, 1998.
58. Little MP, Hawkins MM, Charles MW, Hildreth NG: Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks. Radiat Res 132(2):207-21, 1992.
59. MacMahon B: Prenatal x-ray exposure and childhood cancer. J Natl Cancer Inst 28(1):173-91, 1962.
60. Mancuso TF, Stewart A, Kneale G: Radiation exposures of Hanford workers dying from cancer and other causes. Health Physics 33:369-385, 1977.
61. Miller RW, Boice JD, Jr.: Cancer after intrauterine exposure to the atomic bomb. Radiat Res 147(3):396-7, 1997.
62. Mole RH: Childhood cancer after prenatal exposure to diagnostic X-ray examinations in Britain. Br J Cancer 62(1):152-68, 1990.
63. Montserrat E: Chronic lymphoid leukemias. In Degos L, Linch D, Löwenberg B, (ed): Textbook of malignant hematology. London, Martin Dunitz, 1999, pp 563-91.
64. Moriwaki S, Ray S, Tarone RE, Kraemer KH, Grossman L: The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat Res 364(2):117-23, 1996.
65. National Research Council, Committee on the Biological Effects of Ionizing Radiation (BEIR V): Health effects of exposure to low levels of Ionizing Radiation (BEIR V). Washington, DC: National Academy Press, 1990.
66. Neriishi K, Stram DO, Vaeth M, Mizuno S, Akiba S: The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors. Radiat Res. 125:206-213, 1991.
67. Neubert RT, Delgado I, Webb JR, et al.: Assessing lymphocyte functions in neonates for revealing abnormal prenatal development of the immune system. Teratog Carcinog Mutagen 20(4):171-93, 2000.
68. Oyeyinka GO: Age and sex differences in immunocompetence. Gerontology 30(3):188-95, 1984.
69. Patil SR, Ruddle FH, Lubs HA: The lymphocyte as a dosimeter: comparison of somatic chromosome aberrations in 522 newborn infants and 602 mothers. Humangenetik 14(4):306-13, 1972.
70. Penn I: Depressed immunity and the development of cancer. Cancer Detect Prev 18(4):241-52, 1994.
71. Pierce DA, Mendelsohn ML: A model for radiation-related cancer suggested by atomic bomb survivor data. Radiat Res 152(6):642-54, 1999.
72. Pierce DA, Shimizu Y, Preston DL, et al: Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res 146(1):1-27, 1996.
73. Pierce DA, Vaeth M, Preston DL: Analysis of time and age patterns in cancer risk for A-bomb survivors. Radiat Res 126(2):171-86, 1991.
74. Polednak AP, Frome EL: Mortality among men employed between 1943 and 1947 at a uranium-processing plant. Journal of Occupational Medicine 23(3):169-78, 1981.
75. Portier C, el Masri H: Statistical research needs in mechanistic modelling for carcinogenic risk assessment. Stat Methods Med Res 6(4):305-15, 1997.
76. Prieur M, Al Achkar W, Aurias A, et al.: Acquired chromosome rearrangements in human lymphocytes: effect of aging. Hum Genet 79(2):147-50, 1988.
77. Richardson DB: Time-related factors in radiation-cancer associations among workers at Oak Ridge National Laboratory. University of North Carolina at Chapel Hill; 1997.
78. Richardson DB, Wing S: Final Report: Time-related factors in radiation-cancer dose response. . Cincinnati: National Institute for Occupational Safety and Health, 1997.
79. Richardson DB, Wing S: Methods for investigating age differences in the effects of prolonged exposures. American Journal of Industrial Medicine 33(2):123-130, 1998.
80. Richardson DB, Wing S: Greater sensitivity to ionizing radiation at older age: follow-up of workers at Oak Ridge National Laboratory through 1990. Int J Epidemiol 28(3):428-36, 1999.
81. Ritz B: Radiation exposure and cancer mortality in uranium processing workers. Epidemiology 10(5):531-8, 1999.
82. Ritz B, Morgenstern H, Froines J, Young BB: Effects of exposure to external ionizing radiation on cancer mortality in nuclear workers monitored for radiation at Rocketdyne/Atomics International. Am J Ind Med 35(1):21-31, 1999.
83. Ritz B, Morgenstern H, Moncau J: Age at exposure modifies the effects of low-level ionizing radiation on cancer mortality in an occupational cohort. Epidemiology 10(2):135-40, 1999.
84. Ron E, Lubin JH, Shore RE, et al.: Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141(3):259-77, 1995.
85. Ron E, Modan B, Boice JD, Jr.: Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol 127(4):713-25, 1988.
86. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD, Jr.: Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 120(3):516-31, 1989.
87. Ruddon R: Molecular and genetic events in neoplastic transformation. In Schottenfeld D, Fraumeni J, (ed): Cancer Epidemiology and Prevention. 2nd ed. New York, Oxford, Oxford University Press, 1996, pp 80-100.
88. Sadeghi HM, Schnelle JF, Thoma JK, Nishanian P, Fahey JL: Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol 34(8):959-70, 1999.
89. Shepard JS, Ferrari I: Stage sensitivity and dose response in human leukocytes. Radiat Res 44(3):855-66, 1970.
90. Shimizu Y, Kato H, Schull WJ: Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Radiat Res 121(2):120-41, 1990.
91. Shimizu Y, Pierce DA, Preston DL, Mabuchi K: Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiat Res 152(4):374-89, 1999.
92. Shimizu Y, Schull WJ, Kato H: Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation. JAMA 264(5):601-4, 1990.
93. Shore RE, Albert RE, Pasternack BS: Follow-up study of patients treated by X-ray epilation for Tinea capitis; resurvey of post-treatment illness and mortality experience. Arch Environ Health 31(1):21-8, 1976.
94. Shore RE, Albert RE, Reed M, Harley N, Pasternack BS: Skin cancer incidence among children irradiated for ringworm of the scalp. Radiat Res 100(1):192-204, 1984.
95. Smith PG, Doll R: Late effects of x irradiation in patients treated for metropathia haemorrhagica. Br J Radiol 49(579):224-32, 1976.
96. Smith PG, Doll R: Age- and time-dependent changes in the rates of radiation-induced cancers in patients with ankylosing spondylitis following a single course of X-ray treatment. In: Late biological effects of ionizing radiation. Vol. I. Vienna, International Atomic Energy Agency,:205-18, 1978.
97. Smith PG, Doll R: Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J Clin Res Ed 284(6314):449-60, 1982.
98. Smith PG, Doll R, Radford EP: Cancer mortality among patients with ankylosing spondylitis not given X-ray therapy. Br J Radiol 50(598):728-34, 1977.
99. Sposto R, Preston DL, Shimizu Y, Mabuchi K: The effect of diagnostic misclassification on noncancer and cancer mortality dose response in A-bomb survivors. Biometrics 48(2):605-17, 1992.
100. Steenland K, Stayner L: The importance of employment status in occupational cohort mortality studies. Epidemiology 2(6):418-423, 1991.
101. Stewart A: Prenatal radiation exposure and childhood cancer. Lancet 1(702):751-2, 1971.
102. Stewart A: Prenatal x-ray exposure and childhood neoplasms. Br J Radiol 45(538):794, 1972.
103. Stewart A: Childhood cancers and competing causes of death. Leukemia Research 19(2):103-11, 1995.
104. Stewart A: Risk estimation for badge-monitored radiation workers. Environ Health Perspect 105(S6):1603-1606, 1997.
105. Stewart A: The role of epidemiology in the detection of harmful effects of radiation. Environ Health Perspect 108(2):93-6, 2000.
106. Stewart A, Kneale GW: Childhood cancer following obstetric radiography. Health Physics 24(3):359, 1973.
107. Stewart A, Webb J, Giles D, Hewitt D: Malignant disease in childhood and diagnostic irradiation in utero. Lancet 2:447, 1956.
108. Stewart AM, Kneale GW: The immune system and cancers of foetal origin. Cancer Immunology, Immunotherapy 14(2):110-6, 1982.
109. Stewart AM, Kneale GW: A-bomb survivors: further evidence of late effects of early deaths. Health Physics 64(5):467-72, 1993.
110. Stewart AM, Kneale GW: A-bomb survivors: factors that may lead to a re-assessment of the radiation hazard. Int J Epidemiol 29(4):708-714, 2000.
111. Stuttgart GT: [Chromosomal investigations in two age groups of human females]. Aktuelle Gerontol 7(1):23-33, 1977.
112. Swift M, Morrell D, Massey RB, Chase CL: Incidence of cancer in 161 families affected by ataxiatelangiectasia. N Engl J Med 325(26):1831-6, 1991.
113. Swift M, Reitnauer PJ, Morrell D, Chase CL: Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316(21):1289-94, 1987.
114. Thompson DE, Mabuchi K, Ron E, et al.: Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 137(2 Suppl): S17-67, 1994.
115. Tucker JD, Lee DA, Ramsey MJ, Briner J, Olsen L, Moore DH, 2nd: On the frequency of chromosome exchanges in a control population measured by chromosome painting. Mutat Res 313(2-3):193-202, 1994.
116. United Nations Scientific Committee on the Effects of Atomic Radiation: Sources and effects of ionizing radiation. New York: United Nations, 1977.
117. United Nations Scientific Committee on the Effects of Atomic Radiation: Sources, effects, and risks of ionizing radiation. New York: United Nations, 1988.
118. Virsik RP, Harder D: Recovery kinetics of radiation-induced chromosome aberrations in human GO lymphocytes. Radiat Environ Biophys 18(3):221-38, 1980.
119. Virsik RP, Schafer C, Harder D, Goodhead DT, Cox R, Thacker J: Chromosome aberrations induced in human lymphocytes by ultrasoft Al (K) and C (K) X-rays. Int J Radiat Biol Relat Stud Phys Chem Med 38(5):545-57, 1980.
120. Vormittag W: [Age dependence of chromosomal findings]. Acta Med Austriaca 4(1):1-6, 1977.
121. Watts J: Japan's hibakusha still battle the effects of US nuclear bombs. Lancet 356:1009, 2000.
122. Weiss B: Vulnerability to pesticide neurotoxicity is a lifetime issue. Neurotoxicology 21(1-2):67-73, 2000.
123. Weiss HA, Darby SC, Doll R: Cancer mortality following X-ray treatment for ankylosing spondylitis. International Journal of Cancer 59(3):327-38, 1994.
124. Weiss HA, Darby SC, Fearn T, Doll R: Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiat Res 142(1):1-11, 1995.
125. Wnitaker SJ, Ung YC, McMillan TJ: DNA double-strand break induction and rejoining as determinants of human tumour cell radiosensitivity. A pulsed-field gel electrophoresis study. Int J Radiat Biol 67(1):7-18, 1995.
126. Wing S, Richardson DB, Wolf S, et al: A case control study of multiple myeloma at four nuclear facilities. Ann Epidemiol 10(3): 144-53, 2000.
127. Wing S, Shy CM, Wood JL, Wolf S, Cragle DL, Frome EL: Mortality among workers at Oak Ridge National Laboratory. Evidence of radiation effects in follow-up through 1984. JAMA 265(11):1397-402, 1991.
128. Yoshimoto Y: Cancer risk among children of atomic bomb survivors. A review of RERF epidemiologic studies. Radiation Effects Research Foundation. JAMA 264(5):596-600, 1990.
129. Yoshimoto Y, Kato H, Schull WJ: Risk of cancer among children exposed in utero to A-bomb radiations, 1950-84. Lancet 2(8612):665-9, 1988.
130. Yoshimoto Y, Kato H, Schull WJ: A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Cancer risk among in utero-exposed survivors. J Radiat Res 32(Suppl):231-8, 1991.